Summary for ENCSR966CJN
Summary
- Status
- released
- Description
- Functional characterization series for tiling, Cas9/CRISPRk proliferation screens at the GATA1 locus
- Donor diversity
- single
- Assay
- proliferation CRISPR screen
- Biosample summary
- K562 cell line treated with Puromycin genetically modified (insertion) using transduction, genetically modified (CRISPR cutting) using CRISPR , for multiple loci
- Diseases
- Not reported
- Treatments
- Puromycin
- Elements references
- ENCSR145WNY (GATA1, MYB, ZMYND8)
- Tiling modality
- full tiling
Attribution
ENCODE4 project
- Lab
- Will Greenleaf, Stanford
- Award
- UM1HG009436 (Will Greenleaf, Stanford)
- Project
- ENCODE
- Aliases
- will-greenleaf:CRISPRk_GATA1_Tiling_Series
- External resources
- None submitted
Experiments in ENCSR966CJN
Experiments
2 experiments
Accession | Assay | Examined loci | Biosample summary | Lab | Status | Cart |
|---|---|---|---|---|---|---|
| ENCSR141ZPC | proliferation CRISPR screen | Homo sapiens K562, 7 days post-nucleic acid delivery time genetically modified (insertion) using transduction, using CRISPR cutting (sgRNA) for multiple loci | Will Greenleaf, Stanford | released | ||
| ENCSR303GYT | proliferation CRISPR screen | Homo sapiens K562, 21 days post-nucleic acid delivery time genetically modified (insertion) using transduction, using CRISPR cutting (sgRNA) for multiple loci | Will Greenleaf, Stanford | released |
Control experiments
1 control experiment
Accession | Control type | Biosample summary | Lab | Status | Cart |
|---|---|---|---|---|---|
| ENCSR479VDK | control | Will Greenleaf, Stanford | released |